We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current UTMD market cap is 208.08M. The company's latest EPS is USD 4.9047 and P/E is 12.49.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 12.51M | 12.33M | 11.34M | 10.4M | 10.01M |
| Operating Income | 3.97M | 3.94M | 3.88M | 3.44M | 3.34M |
| Net Income | 3.94M | 4.29M | 3.96M | 3.45M | 3.56M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 46.9M | 42.18M | 49.05M | 52.28M | 50.22M |
| Operating Income | 17.63M | 13.71M | 18.88M | 19.79M | 16.78M |
| Net Income | 14.73M | 10.8M | 14.79M | 16.47M | 16.64M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 131.24M | 135.46M | 135.44M | 130.03M | 129.69M |
| Total Liabilities | 7.54M | 7.15M | 7.7M | 5.98M | 5.5M |
| Total Equity | 123.7M | 128.31M | 127.74M | 124.05M | 124.2M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 109.79M | 111.75M | 115.64M | 123.87M | 135.46M |
| Total Liabilities | 8.69M | 8.92M | 8.5M | 9.62M | 7.15M |
| Total Equity | 101.09M | 102.82M | 107.14M | 114.25M | 128.31M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 16.95M | 22.28M | 5.28M | 8.04M | 11.89M |
| Investing | -549k | -639k | 5k | -110k | -199k |
| Financing | -3.09M | -4.17M | -3.98M | -11.17M | -16.09M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 17.06M | 20.14M | 21.2M | 21.15M | 22.28M |
| Investing | -21.54M | -860k | -552k | -818k | -639k |
| Financing | -4.23M | -10.73M | -10.91M | -5.48M | -4.17M |
| Market Cap | 208.08M |
| Price to Earnings Ratio | 12.49 |
| Price to Sales Ratio | 4.14 |
| Price to Cash Ratio | 2.24 |
| Price to Book Ratio | 1.62 |
| Dividend Yield | 1.99% |
| Shares Outstanding | 3.39M |
| Average Volume (1 week) | 15.97k |
| Average Volume (1 Month) | 21.63k |
| 52 Week Change | -26.65% |
| 52 Week High | 85.76 |
| 52 Week Low | 60.39 |
| Spread (Intraday) | 10.57 (16.82%) |
| Company Name | Utah Medical Products Inc |
| Address |
7043 south 300 west midvale, utah 84047 |
| Website | https://www.utahmed.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
